Locally distributed multicentric plasmacytomas in the ileum secondary to lymphoma chemoimmunotherapy

Ann Hematol. 2019 Jun;98(6):1501-1503. doi: 10.1007/s00277-018-3543-y. Epub 2018 Nov 8.

Authors

Masako Yokoo¹, Kensuke Kojima², Haruna Sano¹, Keita Kai³, Fumiko Arakawa⁴, Koichi Ohshima⁴, Taketo Matsunaga⁵, Shinya Kimura¹

Affiliations

¹ Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.
² Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan. kkojima@cc.saga-u.ac.jp.
³ Department of Pathology, Saga University Hospital, Saga, Japan.
⁴ Department of Pathology, School of Medicine, Kurume University, Kurume, Japan.
⁵ Department of Surgery, Faculty of Medicine, Saga University Hospital, Saga, Japan.

PMID: 30406822
DOI: 10.1007/s00277-018-3543-y

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
B-Lymphocytes / pathology
Cyclophosphamide / administration & dosage
Cyclophosphamide / adverse effects
Doxorubicin / administration & dosage
Doxorubicin / adverse effects
Humans
Ileal Neoplasms / chemically induced*
Immunotherapy / adverse effects*
Lymphoma, Large B-Cell, Diffuse / drug therapy*
Male
Multiple Myeloma / chemically induced*
Neoplasms, Second Primary / chemically induced*
Prednisone / administration & dosage
Prednisone / adverse effects
Rituximab / administration & dosage
Rituximab / adverse effects
Vincristine / administration & dosage
Vincristine / adverse effects

Substances

Rituximab
Vincristine
Doxorubicin
Cyclophosphamide
Prednisone

Supplementary concepts

CHOP protocol

Grants and funding